Synovial Tissue Biopsy Collection by Rheumatologists: Ready for Clinical Implementation? by Smits, M. et al.
PDF hosted at the Radboud Repository of the Radboud University
Nijmegen
 
 
 
 
The following full text is a publisher's version.
 
 
For additional information about this publication click this link.
http://hdl.handle.net/2066/208134
 
 
 
Please be advised that this information was generated on 2019-11-08 and may be subject to
change.
REVIEW
published: 20 June 2019
doi: 10.3389/fmed.2019.00138
Frontiers in Medicine | www.frontiersin.org 1 June 2019 | Volume 6 | Article 138
Edited by:
João Eurico Fonseca,
Universidade de Lisboa, Portugal
Reviewed by:
Serena Bugatti,
University of Pavia, Italy
Vasco C. Romão,
University of Lisbon, Portugal
*Correspondence:
Rogier M. Thurlings
rogier.thurlings@radboudumc.nl
Specialty section:
This article was submitted to
Rheumatology,
a section of the journal
Frontiers in Medicine
Received: 04 December 2018
Accepted: 04 June 2019
Published: 20 June 2019
Citation:
Smits M, van de Groes S and
Thurlings RM (2019) Synovial Tissue
Biopsy Collection by Rheumatologists:
Ready for Clinical Implementation?
Front. Med. 6:138.
doi: 10.3389/fmed.2019.00138
Synovial Tissue Biopsy Collection by
Rheumatologists: Ready for Clinical
Implementation?
Marijn Smits 1, Sebastiaan van de Groes 2 and Rogier M. Thurlings 1*
1Department of Rheumatology, Radboud University Medical Center, Nijmegen, Netherlands, 2Department of Orthopedic
Surgery, Radboud University Medical Center, Nijmegen, Netherlands
Synovial tissue from arthritis patients is increasingly used for both basic
pathophysiological and clinical translational research. This development has been
spurred by the development of biotechnological techniques for analysis of complex
tissues and the validation of ultrasound guided biopsies for easier tissue sampling. This
increasing use of synovial tissue raises questions on standardization of methodologies for
tissue processing and cellular & molecular analyses. Furthermore, it raises the question
if synovial tissue biopsy analysis may be more widely implemented in clinical practice,
what are the methodological hurdles for implementation and what are the lessons that
can be learned from previous experience. This will be the focus of this review.
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ACQUIREMENT OF SYNOVIAL BIOPSIES
There are several possible approaches to the acquisition of synovial tissue (1, 2). In most clinical
practices tissue acquisition is performed by orthopedic surgeons at the operating theater, with the
patient under sufficient anesthesia. For large joints arthroscopic biopsy is generally accepted as the
gold standard, which gives a good quality and size of biopsy specimens in most cases (3). To acquire
sufficient tissue from small joints an arthrotomy could be performed. During the past 25 years
arthoscopic biopsy procedures have been increasingly used by academic rheumatological expert
groups for basic pathophysiologic and clinical translational research. A number of their studies
have addressed the minimal requirements for arthroscopic or ultrasound guided synovial tissue
biopsies for scientific research.
In these studies the minimum number of biopsies to be retrieved was addressed. A minimum of
6 biopsies per procedure was shown to be sufficient to reduce sample variability in T cell numbers
as analyzed by immunohistochemistry (2, 4–6). Other papers addressed the locations in the joint
from which synovial biopsies should be acquired. It was found that macrophages and associated
cytokines were unevenly distributed within the joint, while T cells and expanded T cell clones were
more evenly distributed (7–9). The amount of synovial tissue needed depends on the clinical or
translational questions and further research is needed for validation.
ULTRASOUND-GUIDED SYNOVIAL BIOPSIES
A relatively new method to obtain synovial tissue is ultrasound (US) guided synovial biopsy, which
is performed by trained rheumatologists. It can be performed by portal and forceps or Quick
core needle. US biopsies are less invasive than arthroscopic biopsies and can be performed in
both small and large joints (3, 6, 10–12). An advantage of US biopsy is that it is relatively easy
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to learn and it has a relatively small chance on side effects.
A caveat is that synovial tissue yield is operator and index
joint dependent and the operator needs to perform biopsies
at regular intervals to retain skills to maintain a high success
rate in obtaining good quality synovial tissue samples (6). The
minimal requirements to retain skills is the subject of ongoing
investigations. Furthermore, synovial tissue yield depends on the
level of synovial inflammation as visualized by ultrasound. This
seems to limits the application into research for conditions with
low level of gray scale synovitis. Good quality synovial tissue was
obtained from the knee in a cohort of RA patients in disease
remission, but the success rate and tissue quality was not precisely
reported (13). It has been shown that US guided synovial biopsies
of joints selected on ultrasound parameters yield synovial tissue
in 80–90% of cases of sufficient quality for histological evaluation
and RNA extraction in both small and large joints (6). One study
showed that the histological analysis of 2.5 mm2 from 4 biopsies
of synovial tissue acquired by US biopsies is representative
of the joint status in small joints of RA patients (14). In a
recent multicenter retrospective study comparing arthroscopic
biopsies with ultra-sound guided and blind needle biopsies
on 159 procedures from 5 different academic rheumatology
centers, there was no significant difference in the proportion
of graded synovial tissue or total graded synovial tissue area
and containing enough RNA of significant quality and quantity
for transcriptomic analysis (15). These studies on tissue quality
have only been investigated for a number of general assays,
such as immunohistochemical staining of T cells and general
retrieval of RNA. These diagnostic tests are not used in the
clinical setting. Studies for these diagnostic tests have not been
performed. It is therefore not precisely known what the density
is of pathophysiological aberrations measured with various
techniques or if there is an uneven distribution of biomarkers
for different clinical conditions. Furthermore, if a number of
diagnostic tests are combined within one patient, it is not
known if the synovial tissue yield is similar between the first vs.
later biopsies.
Clinical Value of Synovial Tissue Sampling
Most clinical translational research focuses on prognostication
and prediction of treatment response in patients with rheumatoid
arthritis or psoriatic arthritis. To better understand the hurdles
toward clinical implementation of potential biomarkers it is
informative to critically appraise the use of synovial tissue
diagnostic tests in current clinical practice. At this moment,
synovial tissue analysis is infrequently used for differential
diagnosis in patients with arthritis. There are many different
causes of arthritis. For the rheumatologist it is frequently
problematic to discriminate between these different causes. In
a patient with arthritis the rheumatologist first analyzes the
development in time and the number and pattern of involved
joints. A major distinguishing factor for differential diagnosis
is the presence of a mono- vs. oligo- or polyarthritis. Second,
investigations such as imaging studies and blood tests may give
additional clues for the cause. Also, examination of synovial fluid,
when it is possible to aspirate this, can be of aid. Despite this,
the rheumatologist can often not make a certain diagnosis (16).
In most clinical practices synovial biopsies are performed by
surgeons. Unfortunately, this can result in considerable delay.
Sometimes, a biopsy is even omitted and patients are first
treated with a trial of immunosuppressants and a biopsy is only
performed if they do not respond. This can result in a prolonged
period before an effective treatment is found with a long
period of illness, invalidity and risk on permanent joint damage.
Implementation of synovial biopsy sampling in these patients
is also hampered by the relative limited amount of scientific
reporting on this issue. In various case reports and series synovial
biopsy analysis has shown an added value in addition to other
diagnostic tests (17). From these reports it is however not entirely
clear in which circumstances a synovial biopsy may precisely aid
in diagnosis and what are the chances on sampling error. This is
relevant because ultrasound-guided synovial biopsies are smaller
compared to arthroscopic or arthrotomic tissue specimens. A
careful reading of reported literature may give clues to the
opportunities and hurdles for implementation in clinical practice
for synovial biopsy analysis with existing diagnostic tests and
this may also give insight into the hurdles for implementation
of potential future diagnostic tests.
Infectious Arthritis
There are many different pathogens that can infect synovial
tissue. Below we discuss different causes of infectious arthritis
and the value of synovial tissue analysis.
Acute Infectious Arthritis
Synovial tissue analyses can assist in the detection of joint
infections (18). Most infections present as an acute onset
mono-arthritis accompanied by fever. Less frequently, infectious
arthritis presents as an indolent mono- or oligoarthritis.
Causative organisms range from common gram-positive and
gram-negative bacteria to gonococci, Borrelia Burgdorpheri,
mycobacteria, fungi, or TropherymaWhippleii infection. Synovial
fluid culture yields growth of pathogenic bacteria in only
a proportion of cases depending on the causative organism.
Synovial fluid with a nucleated cell count ≥2,000 white blood
cells/mm3 is considered inflammatory, the higher the leukocyte
count (>10,000/mm3) and the greater the percentage of
polymorphonuclear neutrophils (PMNs) (>90%), the higher the
likelyhood of septic arthritis (19). Bacterial joint infections often
have more than 75% of PMNs (20). In a recent study Coiffier
et al. performed ultrasound guided synovial biopsies in patients
with an acute monoarthritis (defined as <6 weeks duration). A
total of 51 synovial biopsies were obtained from these patients
from which 11 were positive on culture and defined as septic
arthritis. Three of these biopsies had a positive synovial tissue
culture and no bacterial growth on synovial fluid. This suggests it
is useful to obtain synovial tissue in patients with an acute mono-
arthritis and negative synovial fluid culture. Also the presence of
perivascular infiltration of neutrophils in synovial tissue had a
sensitivity and specificity of, respectively, 81.8 and 842% which
leads to a likelyhood of 5,2 for the diagnosis septic arthritis (21).
Neisseria gonorrhoeae septic arthritis is often difficult to
diagnose, for which mostly PCR or culturing on synovial fluid
is performed. N. Gonorrhoeae is fragile and difficult to grow (22)
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The Gram stain reveals intra- and extracellular Gram-negative
diplococci in <50% of cuture-positive fluids. Polymerase chain
reaction (PCR) for N. Gonorrhoeae has a high specificity, which
is estimated at 96–98% and a sensitivity of 78–80% (22). Broad-
range bacterial primers to analyze genes coding for ribosomal
RNA (16S rRNA) by polymerase chain reaction (PCR) may
also show bacterial species (23–25). The available literature on
the performance of these diagnostic tests mostly consists of
case reports and series. It is therefore unknown in which cases
and to what extent synovial tissue analysis is of added value
compared to synovial fluid analysis. The use of 16S rRNA in
diagnosis is for example under discussion since this test has
also been reported positive in cases of rheumatoid arthritis and
spondyloarthritis (25, 26). 16S rRNA analysis has also yielded
positive results in uninfected liver and lymph node specimens.
It is thought that this may be caused by amplification of
RNA from bacterial fragments in endosomes of macrophages.
In these cases 16S rRNA mostly yielded multiple organisms.
Infectious arthritis might be characterized by the presence of
rRNA from a single organism in multiple tissue specimens
(27–29). A single study suggested that serial sampling could
help in the decision to discontinue antibiotic treatment (29).
However, the minimum amount of tissue that is required for
immunohistochemical staining, culture and RNA analysis has
not yet been systematically investigated.
Lyme Arthritis
A number of studies have focused on synovial tissue analysis
in Lyme arthritis (23, 30–37). Lyme disease is a tick-borne
infectious disease caused by different subspecies, most often
Borrelia Burgdorferi, B. Garinii, and B. Afzelii. Lyme arthritis
most common present as an intermittent or chronic mono-
arthritis of the knee joint and less common an asymmetrical
oligoarthritis (23). The causative agents and disease course and
manifestations vary between continents. In the USA Borrelia
Burgdorferi is the primary cause of Lyme disease (38). In Europe
Lyme arthritis is most commonly caused by B. afzelii, B. garini,
and B. burgdorferi occurs less often (39). About 60% of the
untreated patients with Lyme disease develop Lyme arthritis as
a manifestation of Lyme disease and about 10% of these do not
respond to antibiotics (23, 36). Hypothetical explanations for
this problem include the persistent presence of the organism or
development of post-infectious inflammatory arthritis. Borrelia
Burgdorpheri grows in blood and skin biopsies, but synovial
fluid is a toxic environment for Borrelia species and successful
cultivation is rarely seen (31, 32, 37). In spiked cultures adding
small amounts of joint fluid results in rapid killing of spirochetes.
For the diagnosis of Lyme disease it is recommended to use a two
test approach for active disease and for previous infection using
a sensitive enzyme immunoassay (EIA) or immunofluorescent
assay (IFA) followed by a Western immunoblot. Negative EIA
or IFA make a diagnosis of Lyme arthritis highly unlikely and
remove the need for further testing (40). Lyme arthritis is a late
stage of Lyme borreliosis and occurs several months after initial
infection. Persons tested for Lyme disease almost always have
a strong IgG positive response to Borrelia Burgdorpheri or blot
antigens (41). However, positive serology may also reflect past
(asymptomatic) Lyme infection.
PCR testing of synovial fluid for Borrelia Burgdorpheri DNA
may be helpful for establishing a diagnosis of Lyme arthritis.
There are different ways of PCR testing, qualitative PCR and
quantitative PCR testing which detect different DNA sites
encoding for Borrelia Burgdorpheri genes. Sensitivity of PCR
testing on synovial fluid varies between 76 and 88% depending
on which test is used in patients with clinical suspected Lyme
arthritis and positive serology (30). Lyme arthritis can respond
to antibiotic treatment despite a negative baseline Borrelia-PCR
(23, 31, 32, 36). PCR-results vary, because technical execution
is variable and different primer sets against different genes and
subtypes of Borrelia Burgdorpheri are used. It is uncertain to what
extent the sensitivity of Borrelia-PCR testing is diminished by
cytotoxic effects of the synovial fluid on live Borrelia bacteria shed
from the synovial tissue. Borrelia-PCR positivity often decreases
after successful antibiotic treatment but may also persist. It
persists more often in those with antibiotic refractory arthritis,
but it may also disappear without further antibiotic treatment
and does not correlate with time to remission in patients treated
with DMARDs (33). This suggests that a persistent positive
Borrelia-PCR test may result from either persisting living bacteria
or prolonged but temporary presence of bacterial components in
the absence of living bacteria in the synovial tissue.
Data on synovial tissue are limited. In two European studies
Borrelia-PCR remained positive in the synovial tissue but
negative in the synovial fluid in a small number of patients with
Lyme arthritis persisting 2 months after antibiotic therapy. In
one of these studies arthritis resolved post or propter additional
antibiotic treatment (30, 34). In two USA studies Borrelia PCR
was negative in all patients with antibiotic refractory arthritis
7–12 months after multiple antibiotic treatments (32, 33). In
another study it was shown that susceptibility to antibiotic
treatment differs between Borrelia subtypes so data between
Europe and the USA may not be well comparable (31).
Furthermore, it is uncertain if a positive Borrelia-PCR that
persists in the synovial tissue despite antibiotic treatment reflects
persisting live or dead/moribund bacteria. Other tests that may
better reflect Borrelia viability, such as detection of Borrelia-
mRNA, have been developed but not tested in this context (32).
At the same time there is a lack of data on Borrelia species
in the synovial tissue vs. fluid of patients with a persistent
arthritis despite first-line antibiotic treatment. Overall, it can be
clinically difficult to diagnose Lyme arthritis and to determine
if the persisting arthritis is caused by persistent infection, post-
infectious reactive arthritis or another rheumatological disease
and challenging to manage the optimal duration of antibiotic vs.
immunosuppressive treatment. Performance of current or new
diagnostic tests in synovial tissue biopsies might be of added
value, but this is uncertain.
Mycobacterial Arthritis
Tuberculous and non-tuberculous mycobacteria are an
infrequent cause of arthritis and diagnosis is typically delayed
from 5 to 50 months because of low initial clinical suspicion
because of the very indolent onset, accounting 7% of all
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extrapulmonary tuberculosis (42) These patients most often
present with a slowly progressive and destructive monoarthritis,
mostly affecting knee and hip, while systemic symptoms can
be absent. Chest radiography shows pulmonary involvement
in around 50% of patients with osteoarticular tuberculosis.
Tuberculin skin and quantiferon assay maybe falsely negative
as a result from immunosuppression or natural waning of
protective immunity. Ziehl-Nielsen is only positive in 10–20%
of cases and cultures of synovial fluid in 80% and synovial tissue
in 94% (42, 43). Histology showed caseating granulomatous
inflammation in 90% of specimens, which can be hard to
discriminate from granulomatous inflammation in other
conditions including fungal joint disease, sarcoidosis, erythema
nodosum, Brucellosis, Crohn’s disease, and foreign body giant
cell reaction (42). Diagnosis is made with PCR and/or culture
in synovial fluid or tissue (24, 44). Synovial biopsy culture may
be positive while culture of synovial fluid and blood is negative.
In one series in 20% of all cases synovial biopsies were needed
to detect M. tuberculosis (43). Mycobacterial infection may also
result in a type of reactive oligo- or polyarthritis called Poncet’s
disease. In these cases it may be particularly challenging to
discriminate infectious from reactive arthritis. Data lacks on the
minimum amount of tissue to be acquired for the performance
of relevant diagnostic tests.
Mycobacterium leprae can occur without cutaneous
manifestations and present with articular features, mostly
combined with neurologic involvement. Acute and chronic
symmetric polyarthritis of hands, wrists, elbows and knees, and
tenosynovitis are described. It may result from direct infiltration
of the synovial membrane with M. Lepra bacilli or because of
reactive arthritis. Occasionally, Lepra bacilli have been reported
in synovial biopsies, but it has not been investigated how much
synovium should be acquired to differentiate infectious from
reactive arthritis (45).
Non-tuberculous mycobacteria (NTM) are very slowly
growing bacteria and need special medium and prolonged
incubation. PCR techniques are less sensitive but faster to
diagnose NTM and can distinguish mycobacterium tuberculosis
from non-tuberculous mycobacteria. Chronic granulomatous
infection of tendon sheats, bursa, joints, and bone are most
commonly caused by Mycobacterium marinum, Mycobacterium
avium intracellulare M kansasii,M terrae complex,M. Abscessus,
M. Fortuitum, and M chelonae most commonly seen in immune
compromised patients. Surgical excision and antibiotic therapy
is needed in these patients to prevent musculoskeletal damage
(46, 47).
M. Whipple
Whipple’s disease is caused by Tropheryma Whipplei, 65–90%
presents with arthralgias. It typically presents as a chronic,
often migratory and intermittent polyarthritis (48). It is most
often accompanied by gastrointestinal complaints, signs of
malabsorption, and in a proportion of patients, neurological, and
cardiac complaints. A diagnosis is made by PAS staining and PCR
from duodenal or jejunum biopsies, but has also been reported
from blood, synovial fluid, or synovial tissue (48).
Local Proliferative Conditions
Local proliferative and neoplastic conditions often result in
abnormalities in conventional, ultrasound, or MRI images
(49). However, these are absent in some cases, while specific
pathological changes can be detected in the synovial tissue
(50, 51). Synovial chondromatosis is a rare, benign condition
that can occur as a primary condition but also secondary to
joint damage. It involves metaplasia of synovial tissue into
cartilaginous nodules. These gradually enlarge en eventually
break loose to form intra- and periarticular loose bodies. These
may ossify, continue to grow and induce tissue destruction.
Especially at this later stage it may be hard to distinguish
from intracapsular chondroma, chondrosarcoma, and there is a
small risk on malignant transformation. Synovial tissue analysis
may assist diagnosis both in very early stage and in late stage
patients (52).
Pigmented villonodular synovitis (PVNS) is a benign disorder
that involves hypertrophy of villonodular synovial tissue that
gradually fills up the joint space. MRI typically shows a low signal
on T1 and T2 eighted images because of hemosiderin content, but
this may be masked by secondary synovitis, hemorrhage, or fat
deposition. Based on imaging it may be difficult to differentiate
from synovial sarcoma, recurrent hemarthrosis, or hemangioma.
Synovial fluid may be bloody, xanthochromic, or clear. Synovial
biopsy is considered the gold standard for diagnosis. It shows
nodular fragments of hemosiderin and fat (53).
Synovial lipoma arborescens is a rare proliferative fatty
process of the synovium. It may develop as a primary process
or secondary to inflammatory or traumatic synovitis (54, 55).
Synovial proliferation may also occur in response to a foreign
body, such as surgery material, wood splinters, plant thorns, or
sea urchin spine (56). Synovial biopsy may assist in diagnosis of
these conditions in cases without clear etiology.
Local Degenerative Conditions:
Recurrent Hemarthrosis
Spontaneous recurrent hemarthrosis is a condition that can occur
secondary to a number of conditions, such as osteoarthritis,
torn lateral menisci, synovial proliferative lesions, or after
arthroplasty. Cases caused by torn lateral menisci may be treated
with meniscectomy and those with a synovial bleeding source
by synovectomy or arterial embolization (57). Synovial tissue
analysis shows hemosiderin depositions and may have assisted in
diagnosis in isolated cases (58–60).
Deposition Diseases
Gout, Pseudogout, Basic Calcium Phosphate
Deposition Disease
Gout, pseudo-gout, and basic calcium phosphate deposition
disease cannot always be diagnosed by synovial fluid analysis
but can involve deposits of crystalline material in the synovial
tissue (61–63). In case of suspected gout the tissue should be
preserved with alcohol because the monosodium urate crystals
can dissolve in other fixatives. Sections can be examined using
a polarization microscope or using the DeGolanthal staining
method. In a recent case series a group from Copenhagen
University Hospital, Denmark, introduced the use of synovial
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biopsies to diagnose gout in patients without clinical arthritis or
tophi. Biopsies were performed from MTP or ankle joints of 9
patients suspected of gout. Joints were selected that showed signs
of gout on ultrasound, being intrasynovial hyperechogenicity, or
articular double contours. Biopsy was performed with a sterile
no-touch technique, as used for joint punctures, with an intra-
muscular needle (21 gauge/0.8mm). It showed synovial urate
crystal deposition in 8 out of 9 patients (64). The authors
argue that the 1 case in which no crystals were found might
have been caused by sampling error. Synovial biopsies were
also shown to assist in diagnosis of pseudogout patients with a
seronegative polyarthritis (65). Basic calcium phosphate induced
arthritis is hard to formally prove since the crystals are too
small to be identified by (polarizing) light microscopy. They can
be visualized using the calcium stain alizarin red S. A definite
diagnosis can be made using transmission or scanning electron
microscopy coupled with energy dispersive analysis, but this is
mainly limited to the research setting.
Amyloidosis
Amyloid arthropathy results from deposition of immunoglobulin
free light chains in patients with monoclonal gammopathies,
multiple myeloma, or Waldenström’s macroglobulinemia (66). It
can manifest as joint and peri-articular soft tissue swellings or
as arthritis. Most often it presents as a symmetric polyarthritis
of small and large joints, but sometimes fewer or one joint may
be involved (67). It may be the presenting symptom of multiple
myeloma (68). Patients often have an increased erythrocyte
sedimentation rate, Bence jones proteins in urine, anemia,
hypercalcemia, and/or renal insufficiency. There can be clinical
doubt whether the arthritis is caused by amyloid deposition
in the presence of these clinical parameters. Amyloid deposits
can be detected in the synovial tissue with Congo red staining
with polarization microscopy and most sensitively fluorescent
microscopy or immunohistochemical staining of light chains
(69). Of 70 reported cases synovial biopsy was positive in 69
(99%) cases. In one case synovial biopsy was negative for amyloid
and a subsequent renal biopsy was positive. In another an initial
synovial biopsy was negative, but a subsequent synovial biopsy
was positive. This indicates there sampling error may occur in
this condition.
Hemochromatosis, Wilson’s Disease, Ochronosis
Hemochromatosis involves arthralgia in a proportion of patients,
which frequently involves a metocarpophalangeal osteoarthritis-
like arthropathy. Sometimes a patient may present with episodes
of acute arthritis of various joints that may be caused by
pseudogout. Also case reports have been published of acute
arthritis (70), apparently without signs of pseudogout, where
synovial biopsies showed extensive cellular iron accumulation
(71, 72).
Arthritis has been reported as a manifestation of Wilson’s
disease in isolated case reports. Synovial tissue X-ray energy
spectroscopy of a synovial biopsy yielded the diagnosis in one
case (73, 74).
Ochronosis is a rare genetically inherited metabolic condition
that manifests as dark discoloration of the urine, dark
pigmentation of the skin, and eyes and a progressive axial
and peripheral degenerative arthropathy due to loss of cartilage
integrity. The clinical manifestation and pathology results from
joint replacement surgery sufficed for diagnosis in most reported
cases, but synovial tissue biopsy might have assisted diagnosis
in some cases. It shows necrotic, brown cartilage debris, and
sometimes foreign body type reactions including histiocytes and
giant cells containing ochronotic material (75).
Systemic Proliferative Conditions
Rare systemic proliferative non-infectious conditions and
neoplastic conditions such as histiocytositic conditions,
sarcoidosis, melanoma, leukemia/lymphoma, and metastasis
often can be diagnosed based on pathological changes in
other tissues or organs, but these sometimes lack and
typical synovial tissue pathological changes may yield a
diagnosis (76–78). Histiocytic conditions, such as multicentric
reticulohistiocytosis, Langerhans cell histiocytosis, and Erdheim–
Chester disease, typically involve tissue infiltration of bones, the
reticuloendothelial system and various organs (79–83). They
have been associated with mono-, oligo-, and polyarthritis and
synovial biopsy has assisted in differential diagnosis in multiple
reported cases. It typically shows infiltration by disease associated
histiocyte subtypes and various subset of giant cells (17, 84–86).
OPPORTUNITIES AND HURDLES FOR
CLINICAL IMPLEMENTATION OF
SYNOVIAL TISSUE ANALYSIS
BY RHEUMATOLOGISTS
Opportunities
Taken together, the validation of ultrasound guided synovial
biopsies and development of novel potential diagnostic
tests offers an opportunity for synovial biopsy analysis by
rheumatologists. This is relevant for patients with arthritis
in whom synovial tissue analysis is considered, since tissue
acquisition is currently generally performed by surgeons. This
may lead to a considerable delay. There especially seems to be an
indication for a synovial biopsy in patients with a monoarthritis
where blood, synovial fluid, X-ray and MRI investigations yield
insufficient clues. Still, the jury is out whether a rheumatology
center can best invest in an efficient referral system to their
surgical or radiological colleagues or start performing these
biopsies themselves.
Hurdles
There seem to be some hurdles for implementation of ultrasound
guided biopsies. Case studies concern relatively rare etiologies
and these vary between countries. Furthermore, the technical
approach and analytic yields vary. Besides, the reports often
lack full description of other diagnostic clues. Most importantly,
there is a lack of systematic prospective investigations in at risk
populations. Therefore, it is controversial how often a synovial
biopsy is of added value. It is also not known if ultrasound
guided biopsy can reliably substitute arthroscopic or arthrotomic
procedures, especially when multiple tests need to be performed.
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In a recent case series of 74 patients with undifferentiated arthritis
by Najm et al. (16) synovial biopsy analysis was performed with
ultrasound guided biopsies of large and small joints in a number
of rheumatological expert centers in France. 58 patients had
an acute or chronic monoarthritis, 7 an oligoarthritis, and 6 a
polyarthritis. Biopsy size was assessed sufficient if larger than
0.5 mm2 based on previous literature assessing heterogeneity
of histology in RA (16). The biopsies were of sufficient quality
in 82% of patients, the yield depended on learning curve and
joint accessibility. These allowed a definite diagnosis in 16% of
the patients. Five patients underwent a secondary arthroscopy/-
tomy because of suspicion of a septic arthritis which yielded a
diagnosis of pseudogout in one patient. A case of Lyme and
Whipple were diagnosed based on PCR in 2 patients (16). These
data are promising but a number of questions have not yet been
systematically addressed:
What is the number of procedures that should be performed
yearly to retain skills in routine clinical practice? What is the
minimum of synovial biopsies that should be taken for each
diagnostic test, especially in patients in whommultiple tests need
to be performed (6)? Should different joint sites be biopsied to
exclude specific conditions, such as Borrelia, which might have a
predilection for initial infection of the hamstring tendons (45)?
What is the best quality control to ensure that synovial instead of
other joint tissue is acquired for culture or RNA analysis?
CONCLUSION
Analysis of synovial biopsies has been extensively validated
for experimental research and increasingly for clinical
translational research and clinical practice. Further concerted
international collaboration is needed to understand the utility
of synovial biopsies in clinical decision making in patients
with mono- oligo-, or polyarthritis in the context of other
clinical clues. Furthermore, the technical constraints of
ultrasound guided biopsies need to be studied in comparison
with the gold standard: surgical biopsies. Participation in
research networks or quality registries is essential for successful
clinical implementation.
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